Optical spectroscopy for monitoring bilirubin and hemoglobin levels in neonates

Optical spectroscopy for monitoring bilirubin and hemoglobin levels in neonates - Optical monitoring of neonates

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33261

Enrollment

Registered

2009-11-17

Start date

2009-09-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anemia jaundice

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Known bilirubin and/or hemoglobin blood levels from invasive blood analysis (blood drawn for other reasons than this study).

Exclusion criteria

Exclusion criteria: Unknown bilirubin and hemoglobin levels. Affections that hamper the practical feasibility of the measurements (skin irritations etc.). Observable resistance or discomfort during the measurements for the patient (e.g. increased stress levels). The latter two criteria will be judged by the treating physician and compared to the guidelines of the behavioural code of the Nederlandse Vereniging voor Kindergeneeskunde.

Design outcomes

Primary

Measure	Time frame
The bilirubin and hemoglobin concentrations in the skin and the blood vessels in the skin.	—

Secondary

Measure	Time frame
Influence of age, influence of measurement site, influence of skin thickness, influence of skin type.	—

Countries

Netherlands

Outcome results